NEW YORK (dpa-AFX) – US stocks continued their strong recovery on Tuesday amid further good company data. Economic concerns took a back seat after mixed economic data. The leading Dow Jones Industrial index was listed after a price increase of more than two percent recently 1.23 percent higher to 30,557.62 points. The S&P 500 at the market level
increased by 1.25% to 3723.94 points and the high-tech selection index Nasdaq 100 sustained a 0.92 percent price increase to 11,164.65 points.
Market analyst Craig Erlam of broker Oanda, meanwhile, is still questioning the sustainability of current price gains. “The sense of a bear market rally is still strong,” the expert wrote. He is not convinced that there is much substance behind it, “because the economic environment seems insidious and we do not even know if we have already reached the peak of inflation and the expectations on priced interest rates”.
The US industry increased its production significantly in September and surprisingly significantly from the previous month. Conversely, sentiment in the US housing market deteriorated more than expected in October, as evidenced by the decline in the NAHB housing market index. It is now the tenth consecutive decline. The indicator therefore reached its lowest level since August 2012 if the outbreak of the corona pandemic in spring 2020 is taken into account as a special event.
Goldman Sachs data in particular was seen as a positive company report that supports the good mood of the market
called. Net profits of the industry giant plummeted, but not as much as experts expected. According to RBC analyst Gerard Cassidy, earnings per share were even well above forecast. Driven by this, the Wall Street icon’s shares rose about three percent. A series of results that were mostly well received by the banking sector continued.
However, the stock of the Salesforce software company became Dow’s biggest winner , which increased by 4.8 percent. They benefited from the fact that activist investor Starboard founder Jeff Smith spoke of a significant stake in an interview with US economic broadcaster “CNBC”. The investor therefore sees a lot of potential in the newspapers, which are the third weakest value of the Dow this year at almost 40 percent less.
Meanwhile, the cards of the biotech company Akouos have fired
90 percent due to the pharmaceutical company Eli Lilly
reaches him. Investors who only bought the stock at an intermediate low in early August can expect a fivefold rise. shareholders Eli Lilly
reacted relaxed, the headlines were in place.
At Johnson & Johnson On the other hand, the reaction to the data presented was negative: the stock was one of the few losers of the Dow with a discount of 0.3 percent. Consumer goods and pharmaceuticals group slowed currency effects on sales – adjusted net profit decreased.
ISIN US2605661048 US6311011026 US78378X1072
AXC0288 2022-10-18 / 20: 25
Copyright dpa-AFX business news GmbH. All rights reserved. Redistribution, republication or permanent storage is not permitted without the prior express consent of dpa-AFX.
